<DOC>
	<DOC>NCT01330758</DOC>
	<brief_summary>A study to compare two different tablet formulations of AZD8931 in healthy males and females.</brief_summary>
	<brief_title>A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females</brief_title>
	<detailed_description />
	<criteria>Male or female subjects aged 18 to 55 years Females must have a negative pregnancy test at screening and on admission to the unit, must not be lactating and must be of nonchild bearing potential Body mass index between 19 and 30 kg/m2 and weight at least 50 kg and no more than 100 kg Male subjects must be willing to use barrier methods of contraception Be willing and able to comply with study procedures, restrictions and requirements History of any clinically significant disease or disorder Any clinically significant abnormalities at screening Use of any prescribed or nonprescribed medication within 2 weeks Receipt of another NCE or participation in any other clinical trial within 3 months Subjects who have previously received AZD8931</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Healthy male and non-fertile female volunteers</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>AZD8931</keyword>
</DOC>